Favorable Outcomes in Patients Surviving 5 or More Years after Allogeneic Hematopoietic Stem Cell Transplantation for Hematologic Malignancies

Allogeneic hematopoietic stem cell transplantation (SCT) is a curative treatment for some hematological malignancies. As the overall number of survivors continues to increase, studies systematically examining outcomes in long-term survivors are needed. We studied the clinical and quality of life out...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Le, Robert Quan, Bevans, Margaret, Savani, Bipin N, Mitchell, Sandra A., Stringaris, Kate, Koklanaris, Eleftheria, Barrett, A. John
Format: Artigo
Jezik:Inglês
Izdano: 2010
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2897903/
https://ncbi.nlm.nih.gov/pubmed/20302959
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2010.03.005
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items